Crystagen

Type

Short peptide (bioregulator)

Research area

Bioregulator peptides

Research stage

Laboratory research; limited clinical use outside the U.S.

FDA status

Not an FDA-approved medicine

About Crystagen

A short bioregulator peptide studied mostly in Russian laboratory research related to the immune system.

Where the research stands

Most published work on this compound comes from laboratory, animal or early human studies. Results in those settings don't always carry over to people, and long-term safety data are limited.

Read the studies

Educational information only; not medical advice. Talk to a licensed doctor before using any compound.